Amended Small Company Offering and Sale of Securities Without Registration (d/a)
09 Octobre 2020 - 8:41PM
Edgar (US Regulatory)
o
NoneEntity Type | 0000822370 | MYnd Analytics, lnc. MYnd Analytics, Inc. CNS RESPONSE, INC. STRATIVATION, INC. |
x
Corporation
o
Limited Partnership
o
Limited Liability Company
o
General Partnership
o
Business Trust
o
Other |
| Name of Issuer |
Emmaus Life Sciences, Inc. |
| Jurisdiction of Incorporation/Organization |
| DELAWARE |
| |
| Year of Incorporation/Organization |
| |
x
| Over Five Years Ago |
| |
o
| Within Last Five Years (Specify Year) | |
| |
o
| Yet to Be Formed | |
| 2. Principal Place of Business and Contact Information |
| Name of Issuer | |
| Emmaus Life Sciences, Inc. | |
| Street Address 1 | Street Address 2 |
| 21250 HAWTHORNE BOULEVARD | SUITE 800 |
| City | State/Province/Country | ZIP/Postal Code | Phone No. of Issuer |
| TORRANCE | CALIFORNIA | 90503 | 310-214-0065 |
| Last Name | First Name | Middle Name |
| Niihara | Yutaka | |
| Street Address 1 | Street Address 2 |
| 21250 Hawthorne Boulevard | Suite 800 |
| City | State/Province/Country | ZIP/Postal Code |
| Torrance | CALIFORNIA | 90503 |
| Relationship: |
x
| Executive Officer |
x
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
| Last Name | First Name | Middle Name |
| Lee | Willis | |
| Street Address 1 | Street Address 2 |
| 21250 Hawthorne Boulevard | Suite 800 |
| City | State/Province/Country | ZIP/Postal Code |
| Torrance | CALIFORNIA | 90503 |
| Relationship: |
x
| Executive Officer |
x
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
| Last Name | First Name | Middle Name |
| Sherwood | Joseph | |
| Street Address 1 | Street Address 2 |
| 21250 Hawthorne Boulevard | Suite 800 |
| City | State/Province/Country | ZIP/Postal Code |
| Torrance | CALIFORNIA | 90503 |
| Relationship: |
x
| Executive Officer |
o
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
| Last Name | First Name | Middle Name |
| Dickey | Robert | |
| Street Address 1 | Street Address 2 |
| 21250 Hawthorne Boulevard | Suite 800 |
| City | State/Province/Country | ZIP/Postal Code |
| Torrance | CALIFORNIA | 90503 |
| Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
| Last Name | First Name | Middle Name |
| Osato | Masaharu | |
| Street Address 1 | Street Address 2 |
| 21250 Hawthorne Boulevard | Suite 800 |
| City | State/Province/Country | ZIP/Postal Code |
| Torrance | CALIFORNIA | 90503 |
| Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
| Last Name | First Name | Middle Name |
| Zen | Wei | Peu |
| Street Address 1 | Street Address 2 |
| 21250 Hawthorne Boulevard | Suite 800 |
| City | State/Province/Country | ZIP/Postal Code |
| Torrance | CALIFORNIA | 90503 |
| Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
| Last Name | First Name | Middle Name |
| Wood | Jane | Pine |
| Street Address 1 | Street Address 2 |
| 21250 Hawthorne Boulevard | Suite 800 |
| City | State/Province/Country | ZIP/Postal Code |
| Torrance | CALIFORNIA | 90503 |
| Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
| Last Name | First Name | Middle Name |
| Zwicker | Ian | Pine |
| Street Address 1 | Street Address 2 |
| 21250 Hawthorne Boulevard | Suite 800 |
| City | State/Province/Country | ZIP/Postal Code |
| Torrance | CALIFORNIA | 90503 |
| Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
| Clarification of Response (if Necessary) |
| | |
|
o
| Agriculture | | Health Care |
o
| Retailing |
| | Banking & Financial Services | |
o
| Biotechnology |
o
| Restaurants |
| |
o
| Commercial Banking | |
o
| Health Insurance | | Technology |
| |
o
| Insurance | |
o
| Hospitals & Physicians | |
o
| Computers |
| |
o
| Investing | |
x
| Pharmaceuticals | |
o
| Telecommunications |
| |
o
| Investment Banking | |
o
| Other Health Care | |
o
| Other Technology |
| |
o
| Pooled Investment Fund
| | | | | Travel |
| |
o
| Other Banking & Financial Services |
o
| Manufacturing | |
o
| Airlines & Airports |
| | Real Estate | |
o
| Lodging & Conventions |
| |
o
| Commercial | |
o
| Tourism & Travel Services |
| |
o
| Construction | |
o
| Other Travel |
| |
o
| REITS & Finance |
o
| Other |
| |
o
| Residential | |
| |
o
| Other Real Estate | |
|
o
| Business Services | |
| | Energy | |
| |
o
| Coal Mining | |
| |
o
| Electric Utilities | |
| |
o
| Energy Conservation | |
| |
o
| Environmental Services | |
| |
o
| Oil & Gas | |
| |
o
| Other Energy | |
| Revenue Range | Aggregate Net Asset Value Range |
|
o
| No Revenues |
o
| No Aggregate Net Asset Value |
|
o
| $1 - $1,000,000 |
o
| $1 - $5,000,000 |
|
o
| $1,000,001 - $5,000,000 |
o
| $5,000,001 - $25,000,000 |
|
o
| $5,000,001 - $25,000,000 |
o
| $25,000,001 - $50,000,000 |
|
x
| $25,000,001 - $100,000,000 |
o
| $50,000,001 - $100,000,000 |
|
o
| Over $100,000,000 |
o
| Over $100,000,000 |
|
o
| Decline to Disclose |
o
| Decline to Disclose |
|
o
| Not Applicable |
o
| Not Applicable |
| 6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) |
|
o
| Rule 504(b)(1) (not (i), (ii) or (iii)) |
o
| Rule 505 |
|
o
| Rule 504 (b)(1)(i) |
o
| Rule 506(b) |
|
o
| Rule 504 (b)(1)(ii) |
x
| Rule 506(c) |
|
o
| Rule 504 (b)(1)(iii) |
o
| Securities Act Section 4(a)(5) |
| |
o
| Investment Company Act Section 3(c) |
|
o
| New Notice | Date of First Sale | 2020-09-22 |
o
| First Sale Yet to Occur |
| Does the Issuer intend this offering to last more than one year? |
x
| Yes |
o
| No |
| 9. Type(s) of Securities Offered (select all that apply) |
|
o
| Pooled Investment Fund Interests |
o
| Equity |
|
o
| Tenant-in-Common Securities |
o
| Debt |
|
o
| Mineral Property Securities |
x
| Option, Warrant or Other Right to Acquire Another Security |
|
o
| Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security |
x
| Other (describe) |
| | Five year common stock warrants to purchase a total of up to 1,840,000 shares of Emmaus common stock at an exercise price of $2.00 per share and placement agent warrants to purchase up to 75,000 shares at an exercise price of $2.10 per share |
| 10. Business Combination Transaction |
| Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? |
o
| Yes |
x
| No |
| |
| Clarification of Response (if Necessary) | |
| |
| Minimum investment accepted from any outside investor | $ 0 USD |
| Recipient | Recipient CRD Number |
o
| None |
| T.R. Winston & Company LLC | 1415264 |
| (Associated) Broker or Dealer |
x
| None | (Associated) Broker or Dealer CRD Number |
x
| None |
| | |
| Street Address 1 | Street Address 2 |
| 2049 CENTURY PARK E. | SUITE 320 |
| City | State/Province/Country | ZIP/Postal Code |
| LOS ANGELES | CALIFORNIA | 90067 |
| State(s) of Solicitation |
o
| All States |
o
| Foreign/Non-US |
CALIFORNIA
|
| 13. Offering and Sales Amounts |
| Total Offering Amount | $ 3840300 USD |
o
Indefinite |
| Total Amount Sold | $ 3840300 USD | |
| Total Remaining to be Sold | $ 0 USD |
o
Indefinite |
| |
| Clarification of Response (if Necessary) |
| |
|
o
| Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
| |
| | Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: | 18 |
| 15. Sales Commissions & Finders’ Fees Expenses |
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
|
| Sales Commissions | $ 0 USD |
o
| Estimate |
| Finders' Fees | $ 157500 USD |
o
| Estimate |
| |
| Clarification of Response (if Necessary) |
| Paid in the form of the placement agent warrants referred to in item 9 based upon the total exercise price of the placement agent warrants. |
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
|
| | $ 0 USD |
x
Emmaus Life Sciences (QB) (USOTC:EMMA) Graphique Historique de l'Action De Déc 2024 à Jan 2025
Emmaus Life Sciences (QB) (USOTC:EMMA) Graphique Historique de l'Action De Jan 2024 à Jan 2025
Real-Time news about Emmaus Life Sciences Inc (QB) (OTCMarkets): 0 recent articles
Plus d'articles sur Emmaus Life Sciences, Inc.
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
|